Home 📚BioDBS Bibliography database[Title] Analysis of risk signals for Viloxazine in the treatment of attention deficit hyperactivity disorder based on the FAERS database

Analysis of risk signals for Viloxazine in the treatment of attention deficit hyperactivity disorder based on the FAERS database

database[Title] 2025-04-26

Summary:

CONCLUSION: Viloxazine has shown efficacy and tolerability but poses potential safety risks, particularly regarding mood, behavior, and sensory processing. Ongoing monitoring and further studies are needed.

Link:

https://pubmed.ncbi.nlm.nih.gov/40274110/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=12QQbiNmM99eUQGIX1JjHIKcROC1Vzv4sOS-2S_LNI19uG_Yrk&fc=20220129225649&ff=20250426084657&v=2.18.0.post9+e462414

From feeds:

📚BioDBS Bibliography » database[Title]

Tags:

Authors:

Shuai Wang, Ying Jiang, Zhiqiang Du, Rongrong Lu, Xuezheng Gao, Lin Tian, Haohao Zhu

Date tagged:

04/26/2025, 08:47

Date published:

04/24/2025, 06:00